GSK-LPA112356



A randomised, double-blind, placebo-controlled, 3-period cross-over study to evaluate the effect of two doses of GSK2190915 on the allergen-induced early asthmatic response in subjects with mild asthma
fiboflapon
LPA112356
NCT00812773
Asthma
Phase 2
 
June 2015